{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:42:09Z","timestamp":1780393329166,"version":"3.54.1"},"reference-count":136,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:p>Obesity has recently emerged as one of the most severe health concerns. Obesity is a key autonomous risk factor for heart failure and contributes to cardiovascular disease (CVD) risk factors such as hypertension, type 2 diabetes, and metabolic abnormalities. Obesity is caused by a metabolic imbalance, which occurs when calories burnt are fewer than the number of calories consumed. There are several pathways accountable for the adverse impacts of obesity on the cardiovascular system. Inflammatory cell infiltration develops in the adipose tissue, the pancreas, and other issues similar to the progression of obesity. Inflammation is triggered by immune cells that invade dysfunctional adipose tissue. The atherosclerotic inflammation phase, related to obesity, induces coronary calcification. Obesity is linked to elevated levels of leptin and high blood pressure. Leptin causes systemic vasoconstriction, sodium retention, and increased blood pressure by influencing the synthesis of nitric oxide and activating the sympathetic nervous system. Obesity is a well-known risk factor for CVD and is one of the leading causes of the greater risk of diseases, including dyslipidemia, hypertension, depression, metabolic syndrome, atrial fibrillation, and heart failure in adults and children. When used with dietary improvements, antiobesity drugs improve the probability of experiencing clinically healthy (5%) weight loss. This review aimed to address the consequences of obesity on cardiac structure and function, risk factors, the impact of the obesity paradox, pharmacological treatment strategies for managing and recommended exercise and diet.<\/jats:p>","DOI":"10.1097\/mrr.0000000000000565","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T19:09:58Z","timestamp":1675364998000},"page":"14-25","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Association of obesity and cardiovascular disease and progress in pharmacotherapy: what is next for obesity?"],"prefix":"10.1097","volume":"46","author":[{"given":"Manthar Ali","family":"Mallah","sequence":"first","affiliation":[{"name":"College of Public Health, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahmina","family":"Soomro","sequence":"additional","affiliation":[{"name":"Department of Sociology, Shah Abdul Latif University, Khairpur"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobia","family":"Noreen","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukhtiar","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering, Quaid-e-Awam University of Engineering, Science and Technology, Nawabshah, Sindh, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akriti","family":"Kafle","sequence":"additional","affiliation":[{"name":"Nursing School, College of Public Health, Zhengzhou University, Zhengzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafeesa","family":"Khatoon","sequence":"additional","affiliation":[{"name":"College of Public Health, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Naveed","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, School of Pharmacy, Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"key":"R1-20250525","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1161\/CIRCRESAHA.115.306883","article-title":"Obesity and cardiovascular disease.","volume":"118","author":"Ortega","year":"2016","journal-title":"Circ Res"},{"key":"R2-20250525","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013.","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"R3-20250525","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.trsl.2014.04.010","article-title":"Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management.","volume":"164","author":"Alpert","year":"2014","journal-title":"Transl Res"},{"key":"R4-20250525","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.pcad.2016.01.008","article-title":"Obesity and prevalence of cardiovascular diseases and prognosis-the obesity paradox updated.","volume":"58","author":"Lavie","year":"2016","journal-title":"Prog Cardiovasc Dis"},{"key":"R5-20250525","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jchf.2013.01.006","article-title":"Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure.","volume":"1","author":"Lavie","year":"2013","journal-title":"JACC Heart Fail"},{"key":"R6-20250525","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1161\/CIRCULATIONAHA.115.016801","article-title":"Body mass index, abdominal fatness, and heart failure incidence and mortality: a systematic review and dose-response meta-analysis of prospective studies.","volume":"133","author":"Aune","year":"2016","journal-title":"Circulation"},{"key":"R7-20250525","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jjcc.2013.11.006","article-title":"Adipokines: a link between obesity and cardiovascular disease.","volume":"63","author":"Nakamura","year":"2014","journal-title":"J Cardiol"},{"key":"R8-20250525","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nm.2353","article-title":"B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies.","volume":"17","author":"Winer","year":"2011","journal-title":"Nat Med"},{"key":"R9-20250525","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nm.1994","article-title":"Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice.","volume":"15","author":"Liu","year":"2009","journal-title":"Nat Med"},{"key":"R10-20250525","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2885","article-title":"Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase.","volume":"18","author":"Talukdar","year":"2012","journal-title":"Nat Med"},{"key":"R11-20250525","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1126\/science.1201475","article-title":"Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis.","volume":"332","author":"Wu","year":"2011","journal-title":"Science"},{"key":"R12-20250525","doi-asserted-by":"crossref","first-page":"181643","DOI":"10.1155\/2015\/181643","article-title":"Molecular events linking oxidative stress and inflammation to insulin resistance and \u03b2-cell dysfunction.","volume":"2015","author":"Keane","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"R13-20250525","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/ejcn.2017.74","article-title":"C-reactive protein in Brazilian adolescents: distribution and association with metabolic syndrome in ERICA survey.","volume":"71","author":"Giannini","year":"2017","journal-title":"Eur J Clin Nutr"},{"key":"R14-20250525","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet"},{"key":"R15-20250525","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1093\/eurheartj\/ehy310","article-title":"Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS).","volume":"39","author":"Ridker","year":"2018","journal-title":"Eur Heart J"},{"key":"R16-20250525","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","article-title":"Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.","volume":"53","author":"Lavie","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R17-20250525","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/VHRM.S168946","article-title":"Obesity paradox in cardiovascular disease: where do we stand?","volume":"15","author":"Carbone","year":"2019","journal-title":"Vasc Health Risk Manag"},{"key":"R18-20250525","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.jacc.2014.01.022","article-title":"Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox.","volume":"63","author":"Lavie","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R19-20250525","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1136\/heartjnl-2015-307966","article-title":"Body composition and the obesity paradox in coronary heart disease: can heavier really be healthier?","volume":"101","author":"Lavie","year":"2015","journal-title":"Heart"},{"key":"R20-20250525","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0300-595X(76)80023-0","article-title":"Adipose tissue cellularity in human obesity.","volume":"5","author":"Hirsch","year":"1976","journal-title":"Clin Endocrinol Metab"},{"key":"R21-20250525","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1467-789X.2001.00042.x","article-title":"The biology of white adipocyte proliferation.","volume":"2","author":"Hausman","year":"2001","journal-title":"Obes Rev"},{"key":"R22-20250525","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1194\/jlr.M500294-JLR200","article-title":"Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans.","volume":"46","author":"Cinti","year":"2005","journal-title":"J Lipid Res"},{"key":"R23-20250525","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.2337\/db07-0767","article-title":"Adipocyte death, adipose tissue remodeling, and obesity complications.","volume":"56","author":"Strissel","year":"2007","journal-title":"Diabetes"},{"key":"R24-20250525","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"key":"R25-20250525","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue.","volume":"112","author":"Weisberg","year":"2003","journal-title":"J Clin Invest"},{"key":"R26-20250525","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages.","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"R27-20250525","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev-pathol-011110-130138","article-title":"Alternative macrophage activation and metabolism.","volume":"6","author":"Odegaard","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"R28-20250525","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1194\/jlr.E005454","article-title":"The acute phase response inhibits reverse cholesterol transport.","volume":"51","author":"Feingold","year":"2010","journal-title":"J Lipid Res"},{"key":"R30-20250525","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MOL.0b013e32814a645f","article-title":"Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.","volume":"18","author":"Lara-Castro","year":"2007","journal-title":"Curr Opin Lipidol"},{"key":"R31-20250525","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nm.2001","article-title":"Normalization of obesity-associated insulin resistance through immunotherapy.","volume":"15","author":"Winer","year":"2009","journal-title":"Nat Med"},{"key":"R32-20250525","first-page":"255","article-title":"Obesity and coronary artery disease: role of vascular inflammation.","volume":"94","author":"Gomes","year":"2010","journal-title":"Arq Bras Cardiol"},{"key":"R33-20250525","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1590\/S0004-27302006000200016","article-title":"Citocinas, disfun\u00e7\u00e3o endotelial e resist\u00eancia \u00e0 insulina.","volume":"50","author":"Carvalho","year":"2006","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"R35-20250525","doi-asserted-by":"crossref","first-page":"e12997","DOI":"10.1111\/eci.12997","article-title":"Adipokine dysregulation and adipose tissue inflammation in human obesity.","volume":"48","author":"Unamuno","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"R36-20250525","first-page":"376909","article-title":"Adiponectin in cardiovascular inflammation and obesity.","volume":"2011","author":"Aprahamian","year":"2011","journal-title":"Int J Inflam"},{"key":"R37-20250525","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3390\/ijms18061321","article-title":"Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction.","volume":"18","author":"Achari","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R38-20250525","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/obr.12421","article-title":"The incretin system ABCs in obesity and diabetes - novel therapeutic strategies for weight loss and beyond.","volume":"17","author":"Jo\u00e3o","year":"2016","journal-title":"Obes Rev"},{"key":"R39-20250525","doi-asserted-by":"crossref","first-page":"343","DOI":"10.14744\/AnatolJCardiol.2017.7729","article-title":"Inflammatory activity of adipose tissue.","volume":"17","author":"\u0130\u015fcan","year":"2017","journal-title":"Anatol J Cardiol"},{"key":"R40-20250525","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/1806-9282.61.01.072","article-title":"Relationship between adiponectin, obesity and insulin resistance.","volume":"61","author":"Balsan","year":"2015","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"R41-20250525","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/CIRCULATIONAHA.106.171016","article-title":"Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism.","volume":"113","author":"Poirier","year":"2006","journal-title":"Circulation"},{"key":"R42-20250525","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ecl.2008.06.004","article-title":"Impact of obesity on cardiovascular disease.","volume":"37","author":"Zalesin","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R43-20250525","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/ATVBAHA.114.303033","article-title":"Perivascular adipose tissue and coronary vascular disease.","volume":"34","author":"Owen","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R44-20250525","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jcct.2019.03.006","article-title":"State-of-the-art review article. Atherosclerosis affecting fat: what can we learn by imaging perivascular adipose tissue?","volume":"13","author":"Antoniades","year":"2019","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"R45-20250525","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1530\/JOE-14-0283","article-title":"The role of adipose tissue immune cells in obesity and low-grade inflammation.","volume":"222","author":"Mraz","year":"2014","journal-title":"J Endocrinol"},{"key":"R46-20250525","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.hgmx.2016.06.011","article-title":"Low-grade inflammation and its relation to obesity and chronic degenerative diseases.","volume":"80","author":"Castro","year":"2017","journal-title":"Rev M\u00e9d Hosp Gen (M\u00e9xico)"},{"key":"R47-20250525","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-nutr-071811-150623","article-title":"Mechanisms of inflammatory responses in obese adipose tissue.","volume":"32","author":"Sun","year":"2012","journal-title":"Annu Rev Nutr"},{"key":"R48-20250525","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/cvr\/cvx108","article-title":"The role of infiltrating immune cells in dysfunctional adipose tissue.","volume":"113","author":"Guzik","year":"2017","journal-title":"Cardiovasc Res"},{"key":"R49-20250525","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.molmet.2016.12.001","article-title":"JNK at the crossroad of obesity, insulin resistance, and cell stress response.","volume":"6","author":"Solinas","year":"2017","journal-title":"Mol Metab"},{"key":"R50-20250525","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.CIR.71.3.481","article-title":"Noninvasive study of left ventricular performance in obese patients: influence of duration of obesity.","volume":"71","author":"Nakajima","year":"1985","journal-title":"Circulation"},{"key":"R51-20250525","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0002-9149(99)80338-5","article-title":"Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss.","volume":"76","author":"Alpert","year":"1995","journal-title":"Am J Cardiol"},{"key":"R52-20250525","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1751-7133.2011.00264.x","article-title":"Association of left ventricular geometry with left atrial enlargement in patients with preserved ejection fraction.","volume":"18","author":"Patel","year":"2012","journal-title":"Congest Heart Fail"},{"issue":"Suppl 1","key":"R53-20250525","first-page":"A20159","article-title":"Longitudinal impact of childhood BMI on cardiac structure and function.","volume":"134","author":"Baptista de Faria","year":"2016","journal-title":"Circulation"},{"key":"R54-20250525","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/jama.1991.03470020057032","article-title":"The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study.","volume":"266","author":"Lauer","year":"1991","journal-title":"JAMA"},{"key":"R56-20250525","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1161\/01.CIR.0000147184.13872.0F","article-title":"Alterations of left ventricular myocardial characteristics associated with obesity.","volume":"110","author":"Wong","year":"2004","journal-title":"Circulation"},{"key":"R57-20250525","first-page":"416","article-title":"Association of central obesity with the incidence of cardiovascular diseases and risk factors.","volume":"30","author":"Barroso","year":"2017","journal-title":"Int J Cardiovasc Sci"},{"issue":"4 Suppl","key":"R58-20250525","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1353\/hpu.2011.0166","article-title":"Relationships between obesity and cardiovascular diseases in four southern states and Colorado.","volume":"22","author":"Akil","year":"2011","journal-title":"J Health Care Poor Underserved"},{"key":"R59-20250525","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1586\/14779072.2015.1092384","article-title":"The role of cardiorespiratory fitness on plasma lipid levels.","volume":"13","author":"Parto","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R60-20250525","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.jacc.2015.03.517","article-title":"The effect of cardiorespiratory fitness on age-related lipids and lipoproteins.","volume":"65","author":"Park","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R61-20250525","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0002-9149(00)01127-9","article-title":"Evidence that triglycerides are an independent coronary heart disease risk factor.","volume":"86","author":"Cullen","year":"2000","journal-title":"Am J Cardiol"},{"key":"R62-20250525","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archinte.161.11.1413","article-title":"Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality.","volume":"161","author":"Cui","year":"2001","journal-title":"Arch Intern Med"},{"key":"R63-20250525","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1001\/jama.1987.03390160062027","article-title":"Cholesterol and mortality. 30 years of follow-up from the Framingham study.","volume":"257","author":"Anderson","year":"1987","journal-title":"JAMA"},{"key":"R65-20250525","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.metabol.2006.10.019","article-title":"Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women.","volume":"56","author":"Halverstadt","year":"2007","journal-title":"Metabolism"},{"key":"R66-20250525","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"R67-20250525","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III).","volume":"285","year":"2001","journal-title":"JAMA"},{"issue":"25 Suppl 2","key":"R68-20250525","first-page":"S76","article-title":"2013 AHA\/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"129","author":"Eckel","year":"2014","journal-title":"Circulation"},{"key":"R69-20250525","first-page":"CD003817","article-title":"Exercise for overweight or obesity.","volume":"2006","author":"Shaw","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R70-20250525","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.amjhyper.2006.10.011","article-title":"A prospective study of body mass index and the risk of developing hypertension in men.","volume":"20","author":"Gelber","year":"2007","journal-title":"Am J Hypertens"},{"key":"R71-20250525","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0889-8529(18)30105-1","article-title":"Obesity and hypertension.","volume":"23","author":"Hsueh","year":"1994","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R72-20250525","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00000441-200104000-00003","article-title":"Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome.","volume":"321","author":"Alpert","year":"2001","journal-title":"Am J Med Sci"},{"key":"R73-20250525","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/0002-9343(83)91071-9","article-title":"Disparate cardiovascular effects of obesity and arterial hypertension.","volume":"74","author":"Messerli","year":"1983","journal-title":"Am J Med"},{"key":"R74-20250525","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7326\/0003-4819-99-6-757","article-title":"Dimorphic cardiac adaptation to obesity and arterial hypertension.","volume":"99","author":"Messerli","year":"1983","journal-title":"Ann Intern Med"},{"key":"R75-20250525","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/CIRCIMAGING.111.964627","article-title":"Cardiac remodeling in obesity.","volume":"6","author":"Aurigemma","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"R76-20250525","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/CIRCIMAGING.113.000532","article-title":"Relation of regional fat distribution to left ventricular structure and function.","volume":"6","author":"Neeland","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"R77-20250525","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1001\/archinte.165.11.1298","article-title":"Weight loss in overweight adults and the long-term risk of hypertension: the Framingham study.","volume":"165","author":"Moore","year":"2005","journal-title":"Arch Intern Med"},{"key":"R78-20250525","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition.","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"R79-20250525","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report.","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"R80-20250525","doi-asserted-by":"crossref","first-page":"943162","DOI":"10.1155\/2014\/943162","article-title":"A comprehensive review on metabolic syndrome.","volume":"2014","author":"Kaur","year":"2014","journal-title":"Cardiol Res Pract"},{"key":"R81-20250525","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2337\/diacare.28.2.391","article-title":"Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness.","volume":"28","author":"Katzmarzyk","year":"2005","journal-title":"Diabetes Care"},{"key":"R82-20250525","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/diacare.24.4.683","article-title":"Cardiovascular morbidity and mortality associated with the metabolic syndrome.","volume":"24","author":"Isomaa","year":"2001","journal-title":"Diabetes Care"},{"key":"R83-20250525","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2337\/dc10-0665","article-title":"Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study.","volume":"34","author":"Calori","year":"2011","journal-title":"Diabetes Care"},{"key":"R84-20250525","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1016\/j.ijcard.2013.07.230","article-title":"Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies.","volume":"168","author":"Fan","year":"2013","journal-title":"Int J Cardiol"},{"key":"R85-20250525","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pcad.2015.05.001","article-title":"Role of fitness in the metabolically healthy but obese phenotype: a review and update.","volume":"58","author":"Ortega","year":"2015","journal-title":"Prog Cardiovasc Dis"},{"key":"R86-20250525","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrendo.2014.165","article-title":"Healthy obese versus unhealthy lean: the obesity paradox.","volume":"11","author":"Lavie","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"R87-20250525","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jacc.2015.04.057","article-title":"Atrial fibrillation and obesity: not just a coincidence.","volume":"66","author":"Hatem","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R88-20250525","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.hrthm.2012.08.043","article-title":"Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation.","volume":"10","author":"Abed","year":"2013","journal-title":"Heart Rhythm"},{"key":"R89-20250525","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ahj.2007.10.004","article-title":"Atrial fibrillation and obesity--results of a meta-analysis.","volume":"155","author":"Wanahita","year":"2008","journal-title":"Am Heart J"},{"key":"R90-20250525","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1001\/jama.292.20.2471","article-title":"Obesity and the risk of new-onset atrial fibrillation.","volume":"292","author":"Wang","year":"2004","journal-title":"JAMA"},{"key":"R91-20250525","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10741-013-9411-x","article-title":"Atrial fibrillation in heart failure: catheter and surgical interventional therapies.","volume":"19","author":"Rabah","year":"2014","journal-title":"Heart Fail Rev"},{"key":"R92-20250525","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0735-1097(96)00592-X","article-title":"Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies.","volume":"29","author":"Shinbane","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"R93-20250525","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0735-1097(97)00254-4","article-title":"Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation.","volume":"30","author":"Clark","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"R94-20250525","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"R95-20250525","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"key":"R96-20250525","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.amjmed.2017.01.043","article-title":"Interaction of physical activity and body mass index on mortality in coronary heart disease: data from the Nord-Tr\u00f8ndelag Health Study.","volume":"130","author":"Moholdt","year":"2017","journal-title":"Am J Med"},{"key":"R97-20250525","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jacc.2018.01.011","article-title":"Sustained physical activity, not weight loss, associated with improved survival in coronary heart disease.","volume":"71","author":"Moholdt","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R98-20250525","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2010.2","article-title":"Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies.","volume":"67","author":"Luppino","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"R99-20250525","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.pcad.2013.03.010","article-title":"Depression and cardiovascular disease.","volume":"55","author":"Elderon","year":"2013","journal-title":"Prog Cardiovasc Dis"},{"key":"R100-20250525","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"R101-20250525","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1741-7015-9-47","article-title":"Should global burden of disease estimates include depression as a risk factor for coronary heart disease?","volume":"9","author":"Charlson","year":"2011","journal-title":"BMC Med"},{"issue":"10 Suppl 2","key":"R102-20250525","doi-asserted-by":"crossref","first-page":"S365","DOI":"10.1016\/j.cjca.2016.07.508","article-title":"Impact of cardiac rehabilitation and exercise training on psychological risk factors and subsequent prognosis in patients with cardiovascular disease.","volume":"32","author":"Lavie","year":"2016","journal-title":"Can J Cardiol"},{"key":"R103-20250525","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.amjmed.2015.08.012","article-title":"Protective effect of regular physical activity on depression after myocardial infarction: the HUNT study.","volume":"129","author":"Ernstsen","year":"2016","journal-title":"Am J Med"},{"key":"R104-20250525","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.amjmed.2016.07.006","article-title":"Significance of comorbid psychological stress and depression on outcomes after cardiac rehabilitation.","volume":"129","author":"Kachur","year":"2016","journal-title":"Am J Med"},{"key":"R105-20250525","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0006-3223(03)00608-5","article-title":"Depression and obesity.","volume":"54","author":"Stunkard","year":"2003","journal-title":"Biol Psychiatry"},{"key":"R106-20250525","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/sj.mp.4001873","article-title":"Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions.","volume":"11","author":"Bornstein","year":"2006","journal-title":"Mol Psychiatry"},{"key":"R107-20250525","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1177\/1359105308095977","article-title":"Does depression cause obesity?: a meta-analysis of longitudinal studies of depression and weight control.","volume":"13","author":"Blaine","year":"2008","journal-title":"J Health Psychol"},{"key":"R108-20250525","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pcad.2015.12.003","article-title":"Update on obesity and obesity paradox in heart failure.","volume":"58","author":"Lavie","year":"2016","journal-title":"Prog Cardiovasc Dis"},{"key":"R109-20250525","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0002-9149(03)00031-6","article-title":"Body composition and prognosis in chronic systolic heart failure: the obesity paradox.","volume":"91","author":"Lavie","year":"2003","journal-title":"Am J Cardiol"},{"key":"R110-20250525","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.amjcard.2015.02.024","article-title":"Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure.","volume":"115","author":"Sharma","year":"2015","journal-title":"Am J Cardiol"},{"key":"R111-20250525","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/heartjnl-2014-307119","article-title":"Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis.","volume":"101","author":"Wang","year":"2015","journal-title":"Heart"},{"key":"R112-20250525","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2012.113905","article-title":"Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis.","volume":"309","author":"Flegal","year":"2013","journal-title":"JAMA"},{"key":"R113-20250525","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jacc.2012.10.035","article-title":"Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of \u2018normal weight central obesity\u2019.","volume":"61","author":"Coutinho","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R114-20250525","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.jacc.2010.11.058","article-title":"Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data.","volume":"57","author":"Coutinho","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R115-20250525","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/jama.292.10.1179","article-title":"Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women.","volume":"292","author":"Wessel","year":"2004","journal-title":"JAMA"},{"key":"R116-20250525","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.jacc.2010.12.025","article-title":"A prospective study of muscular strength and all-cause mortality in men with hypertension.","volume":"57","author":"Artero","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R117-20250525","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/jama.1996.03540030039029","article-title":"Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women.","volume":"276","author":"Blair","year":"1996","journal-title":"JAMA"},{"key":"R118-20250525","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.yclnex.2018.03.001","article-title":"Gut microbiota and obesity.","volume":"20","author":"Al-Assal","year":"2018","journal-title":"Clin Nutr Exp"},{"issue":"Suppl 1","key":"R119-20250525","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jfma.2018.07.009","article-title":"The gut microbiome in obesity.","volume":"118","author":"Tseng","year":"2019","journal-title":"J Formos Med Assoc"},{"key":"R120-20250525","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/NT.0000000000000167","article-title":"The gut microbiome and its role in obesity.","volume":"51","author":"Davis","year":"2016","journal-title":"Nutr Today"},{"key":"R121-20250525","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(07)60033-6","article-title":"Drug treatments for obesity: orlistat, sibutramine, and rimonabant.","volume":"369","author":"Padwal","year":"2007","journal-title":"Lancet"},{"key":"R122-20250525","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMoa1003114","article-title":"Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.","volume":"363","author":"James","year":"2010","journal-title":"N Engl J Med"},{"key":"R123-20250525","first-page":"831","article-title":"Drug safety evaluation of naltrexone\/bupropion for the treatment of obesity.","volume":"13","author":"Verpeut","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"R124-20250525","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/2230-8210.81938","article-title":"Evaluation of efficacy and safety of orlistat in obese patients.","volume":"15","author":"Jain","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"R125-20250525","first-page":"423","article-title":"New drug therapies for the treatment of overweight and obese patients.","volume":"6","author":"Mahgerefteh","year":"2013","journal-title":"Am Health Drug Benefits"},{"key":"R126-20250525","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1590\/S0004-27302010000600003","article-title":"Progressos Recentes E Novas Perspectivas Em Farmacoterapia Da Obesidade.","volume":"54","author":"Faria","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"R127-20250525","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0\u2009mg of Liraglutide in weight management.","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"key":"R128-20250525","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ijo.2013.120","article-title":"Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study.","volume":"37","author":"Wadden","year":"2013","journal-title":"Int J Obes"},{"key":"R129-20250525","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(17)30069-7","article-title":"3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.","volume":"389","author":"le Roux","year":"2017","journal-title":"Lancet"},{"key":"R130-20250525","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/dom.13125","article-title":"Liraglutide and cardiovascular outcomes in adults with overweight or obesity: a post hoc analysis from SCALE randomized controlled trials.","volume":"20","author":"Davies","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"R131-20250525","first-page":"751","article-title":"Naltrexone HCI\/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives.","volume":"10","author":"Tek","year":"2016","journal-title":"Patient Prefer Adherence"},{"key":"R132-20250525","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ahj.2018.03.012","article-title":"Design and rationale for the cardiovascular and metabolic effects of Lorcaserin in overweight and obese patients-thrombolysis in myocardial infarction 61 (CAMELLIA-TIMI 61) trial.","volume":"202","author":"Bohula","year":"2018","journal-title":"Am Heart J"},{"key":"R133-20250525","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(18)31773-2","article-title":"Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.","volume":"392","author":"O\u2019Neil","year":"2018","journal-title":"Lancet"},{"key":"R134-20250525","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/oby.22794","article-title":"Semaglutide 2.4\u2009mg for the treatment of obesity: key elements of the STEP trials 1 to 5.","volume":"28","author":"Kushner","year":"2020","journal-title":"Obesity (Silver Spring)"},{"key":"R135-20250525","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.","volume":"124","author":"Secher","year":"2014","journal-title":"J Clin Invest"},{"key":"R136-20250525","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00125-016-3874-y","article-title":"Glp-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the Glp-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial [In English].","volume":"59","author":"Farr","year":"2016","journal-title":"Diabetologia"},{"key":"R137-20250525","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fendo.2019.00155","article-title":"The discovery and development of liraglutide and semaglutide.","volume":"10","author":"Knudsen","year":"2019","journal-title":"Front Endocrinol"},{"key":"R138-20250525","doi-asserted-by":"crossref","first-page":"c154","DOI":"10.1136\/bmj.c154","article-title":"Management of obesity: summary of SIGN guideline.","volume":"340","author":"Logue","year":"2010","journal-title":"BMJ"},{"key":"R139-20250525","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/2347-2618.184970","article-title":"Prevention and management of obesity: Saudi guideline update.","volume":"4","author":"Al-Shehri","year":"2016","journal-title":"Saudi J Obes"},{"key":"R141-20250525","doi-asserted-by":"crossref","first-page":"265S","DOI":"10.1093\/ajcn\/82.1.265S","article-title":"The economics of obesity: dietary energy density and energy cost\u2013.","volume":"82","author":"Drewnowski","year":"2005","journal-title":"Am J Clin Nutr"}],"container-title":["International Journal of Rehabilitation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MRR.0000000000000565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T20:06:52Z","timestamp":1748203612000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MRR.0000000000000565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":136,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mrr.0000000000000565","relation":{},"ISSN":["0342-5282"],"issn-type":[{"value":"0342-5282","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,18]]}}}